Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

649521.pdf (590.16 KB)

Document type

Article

Version

Published version

Publication date

2014-12-16

Publication license

cc-by (c) Franco Fernández, Rafael, 2014
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/64745

Enhancing cognition before clinical symptoms of dementia.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.3389/fnsys.2014.00240

Abstract

As the title of the special issue indicates, controversy surrounds augmentation of brain cognition in humans. Lacking efficacious drugs for Alzheimer's disease (AD) and with many AD patients recruited for clinical trials that unfortunately do not provide the expected results, one wonders whether to test cognition enhancement strategies in individuals without symptoms of cognition decline. This opinion article presents the view that safe drugs and or dietary supplements should be tested worldwide in aged individuals under the control of a non-for-profit organization.

Subject

Malaltia d'Alzheimer, Genètica humana, Vitamina C, Inhibidors de fosfodiesterases

Subject (English)

Alzheimer's disease, Human genetics, Vitamin C, Phosphodiesterase Inhibitors

Citation

Collections

Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Citation

FRANCO FERNÁNDEZ, Rafael. Enhancing cognition before clinical symptoms of dementia. Frontiers in systems Neuroscience. 2014. Vol. 8, num. 1-3. ISSN 1662-5137. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/64745

Export metadata

JSON - METS

Share record